AVIR — Atea Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Atea Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	850	764	647	578	455
Net Total Accounts Receivable
Net Total Receivables	5.82	0	—	—	—
Prepaid Expenses
Total Current Assets	863	772	661	590	462
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.048	0.184	4.09	3.12	2.12
Other Long Term Assets
Total Assets	864	773	667	595	465
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	316	56.9	18.5	32.4	18.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	316	62.8	26.1	39.8	25.8
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	548	710	641	555	439
Total Liabilities & Shareholders' Equity	864	773	667	595	465
Total Common Shares Outstanding